MétaCan
Menu
Back to cohort
Record W4390033279 · doi:10.3399/bjgp.2023.0262

Digital intervention (Renewed) to support symptom management, wellbeing, and quality of life among cancer survivors in primary care: a randomised controlled trial

2023· article· en· W4390033279 on OpenAlexaff
Paul Little, Katherine Bradbury, Beth Stuart, Jane Barnett, Adele Krusche, Mary Steele, Elena Heber, Stephanie Easton, Kirsten A. Smith, Joanna Slodkowska‐Barabasz, Liz Payne, Teresa Corbett, Laura Wilde, Guiqing Yao, Sebastien Pollet, Jazzine Smith, Judith Joseph, Megan Lawrence, Dankmar Böhning, Tara Cheetham‐Blake, Diana Eccles, Claire Foster, Adam W A Geraghty, Geraldine Leydon, André Müller, Richard D Neal, Richard H. Osborne, Shanaya Rathod, Alison Richardson, Chloe Grimmett, Geoffrey Sharman, Roger Bacon, Lesley Turner, Richard Stephens, Kirsty Rogers, James Raftery, Shihua Zhu, Karmpaul Singh, Frances Webley, Gareth Griffiths, Jacqueline Nuttall, Trudie Chalder, Clare Wilkinson, Eila Watson, Lucy Yardley

Bibliographic record

VenueBritish Journal of General Practice · 2023
Typearticle
Languageen
FieldMedicine
TopicCancer survivorship and care
Canadian institutionsUniversity of Calgary
FundersProgramme Grants for Applied ResearchNational Institute for Health and Care ResearchCancer Research UKNational Institute for Health Research Southampton Biomedical Research CentreNational Institute for Health Research Health Protection Research Unit
KeywordsMedicineQuality of life (healthcare)Intervention (counseling)Randomized controlled trialCancerPhysical therapyAlternative medicineGerontologyPsychiatryNursingSurgeryInternal medicinePathology

Abstract

fetched live from OpenAlex

Background Many cancer survivors following primary treatment have prolonged poor quality of life. Aim To determine the effectiveness of a bespoke digital intervention to support cancer survivors. Design and setting This was a pragmatic parallel open randomised trial in UK general practices (ISRCTN:96374224). Method People having finished primary treatment (≤10 years previously) for colorectal, breast, or prostate cancers, with European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30) score ≤85, were randomised by online software to: 1) detailed ‘generic’ digital NHS support (‘LiveWell’;n= 906); 2) a bespoke complex digital intervention (‘Renewed’;n= 903) addressing symptom management, physical activity, diet, weight loss, and distress; or 3) ‘Renewed with support’ (n= 903): ‘Renewed’ with additional brief email and telephone support. Results Mixed linear regression provided estimates of the differences between each intervention group and generic advice. At 6 months all groups improved (primary time point:nfor the generic, Renewed groups, and Renewed with support were 806, 749, and 705, respectively), with no significant between-group differences for EORTC QLQ-C30, but global health improved more in both the Renewed groups. By 12 months there were small improvements in EORTC QLQ-C30 for Renewed with support (versus generic advice: 1.42, 95% confidence interval [CI] = 0.33 to 2.51); both Renewed groups improved global health (12 months: Renewed: 3.06, 95% CI = 1.39 to 4.74; Renewed with support: 2.78, 95% CI = 1.08 to 4.48), dyspnoea, constipation and enablement, and lower primary care NHS costs (in comparison with generic advice [£265]: Renewed was −£141 [95% CI = −£153 to–£128] and Renewed with Support was −£77 [95% CI = −£90 to −£65]); and for Renewed with support improvement in several other symptom subscales. No harms were identified. Conclusion Cancer survivors’ quality of life improved with detailed generic online support. Robustly developed bespoke digital support provides limited additional short-term benefit, but additional longer-term improvement in global health, enablement, and symptom management, with substantially lower NHS costs.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.007
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.013
Threshold uncertainty score0.043

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.007
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0040.003
Bibliometrics0.0010.001
Science and technology studies0.0010.002
Scholarly communication0.0010.002
Open science0.0010.001
Research integrity0.0030.002
Insufficient payload (model declined to judge)0.0130.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.020
GPT teacher head0.319
Teacher spread0.299 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations6
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueBritish Journal of General PracticeSame topicCancer survivorship and careFrench-language works237,207